title: Missense splice variant (g.20746A>G, p.Ile183Val) of interferon gamma receptor 1 (IFNGR1) coincidental with mycobacterial osteomyelitis - a screen of osteoarticular lesions.
abstract: Previously, dominant partial interferon-gamma receptor 1 (IFN-g-R1) susceptibility to environmental mycobacteria was found with IFNGR1 deletions or premature stop. Our aim was to search for IFNGR1 variants in patients with mycobacterial osteoarticular lesions. Biopsies from the patients were examined for acid-fast bacilli, inflammatory cell infiltration, and mycobacterial niacin. Mycobacterial rRNA was analyzed using a target-amplified rRNA probe test. Peripheral-blood-leukocyte genomic DNA was isolated from 19 patients using the QIAamp DNA Mini Kit, and all IFNGR1 exons were sequenced using an ABIPRISM 3130 device. After the discovery of an exon 5 variant, a Polish newborn population sample (n = 100) was assayed for the discovered variant. Splice sites and putative amino acid interactions were analyzed. All patients tested were positive for mycobacteria; one was heterozygous for the IFNGR1 exon 5 single-nucleotide-missense substitution (g.20746A>G, p.Ile183Val). No other variant was found. The splice analysis indicated the creation of an exonic splicing silencer, and alternatively, molecular graphics indicated that the p.Ile183Val might alter beta-strand packing (loss of van der Waals contacts; Val183/Pro205), possibly altering the IFN-g-R1/IFN-g-R2 interaction. The probability of non-deleterious variant was estimated as <10%. Heterozygous IFNGR1:p.Ile183Val (frequency 0.003%) was found to be coincidental with mycobacterial osteomyelitis. The small amount of variation detected in the patients with osteoarticular lesions indicates that screens should not yet be restricted: Intronic variants should be analyzed as well as the other genes affecting Type 1 T-helper-cell-mediated immunity.
authors.affiliation: Department of Clinical and Molecular Biochemistry, Pomeranian Medical University in Szczecin, Szczecin, Poland. binia@pum.edu.pl.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Bińczak-Kuleta
authors.forename: Aleksander
authors.initials: A
authors.lastname: Szwed
authors.forename: Mark R
authors.initials: MR
authors.lastname: Walter
authors.forename: Maciej
authors.initials: M
authors.lastname: Kołban
authors.forename: Andrzej
authors.initials: A
authors.lastname: Ciechanowicz
authors.forename: Jeremy S C
authors.initials: JS
authors.lastname: Clark
mesh_terms: D000293:Adolescent; D017398:Alternative Splicing; D019943:Amino Acid Substitution; D001706:Biopsy; D001842:Bone and Bones / Q000473:pathology; D002358:Cartilage, Articular / Q000473:pathology; D002648:Child; D004247:DNA / Q000235:genetics; D005091:Exons; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D007231:Infant, Newborn; D007438:Introns; D008297:Male; D020125:Mutation, Missense; D009165:Mycobacterium Infections, Nontuberculous / Q000235:genetics* / Q000473:pathology; D009163:Mycobacterium bovis / Q000235:genetics* / Q000378:metabolism; D009525:Niacin / Q000378:metabolism; D010019:Osteomyelitis / Q000235:genetics* / Q000473:pathology; D017471:Receptors, Interferon / Q000235:genetics*; D000096743:Interferon gamma Receptor
chemical_list: D004247:DNA; D009525:Niacin; D017471:Receptors, Interferon; D000096743:Interferon gamma Receptor